Invention Grant
- Patent Title: Stabilized glycopeptide antibiotic formulations
-
Application No.: US16300137Application Date: 2017-05-04
-
Publication No.: US10729708B2Publication Date: 2020-08-04
- Inventor: Sabina Keser , Ivona Jasprica , Jerome LeCunff
- Applicant: XELLIA PHARMACEUTICALS APS
- Applicant Address: DK
- Assignee: Xellia Pharmaceuticals APS
- Current Assignee: Xellia Pharmaceuticals APS
- Current Assignee Address: DK
- Agency: McNeill Baur PLLC
- International Application: PCT/EP2017/060653 WO 20170504
- International Announcement: WO2017/194385 WO 20171116
- Main IPC: A61K38/14
- IPC: A61K38/14 ; A61K31/704 ; A61K9/00 ; A61K47/18 ; A61K9/08 ; A61K47/40
Abstract:
Disclosed herein are liquid formulations of glycopeptide antibiotics or pharmaceutically acceptable salts thereof, wherein glycopeptide antibiotic is selected from Vancomycin, Telavancin, Oritavancin, Teicoplanin and Dalbavancin.The formulations are suitable as infusion solutions or as a concentrate for making infusion solutions.
Public/Granted literature
- US20190175632A1 STABILIZED GLYCOPEPTIDE ANTIBIOTIC FORMULATIONS Public/Granted day:2019-06-13
Information query
IPC分类:
